Acquired FGFR and FGF alterations confer resistance to estrogen receptor (ER) targeted therapy in ER+ metastatic breast cancer
Mao, Pingping, Cohen, Ofir, Kowalski, Kailey J, Kusiel, Justin, Buendia-Buendia, Jorge E., Cuoco, Michael S, Exman, Pedro, Wander, Seth A., Waks, Adrienne G, Nayar, Utthara, Chung, Jon H., Freeman, SaJournal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-19-3958
Date:
July, 2020
File:
PDF, 15.55 MB
2020